Selected research
Market Outlook & Growth Opportunities
Global Endoglucanase Market Outlook and Growth Opportunities 2026
Market perspective
The global Endoglucanase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Endoglucanase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Endoglucanase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Endoglucanase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Endoglucanase market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Endoglucanase market include Suzhou Hongxun Biotechnology, Shandong Longda Bio-Products, Ningxia Xiasheng Industrial Group, Hunan Hongying Biotechnology, Guangdong Yiduoli Biotechnology, Sunson Industry, Novozymes, Mitsubishi Chemical Foods and Kerry Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Endoglucanase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Endoglucanase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Endoglucanase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Endoglucanase market size, projected growth trends, production technologies, key applications, and end-use industries.
Endoglucanase Segment by Company
Suzhou Hongxun Biotechnology
Shandong Longda Bio-Products
Ningxia Xiasheng Industrial Group
Hunan Hongying Biotechnology
Guangdong Yiduoli Biotechnology
Sunson Industry
Novozymes
Mitsubishi Chemical Foods
Kerry Group
EN Group
Dyadic Netherlands
DSM
BIO-CAT
Aumgene Biosciences
Amano Enzyme
AB Enzymes
Endoglucanase Segment by Type
Endo-β-1,4-glucanase
Endo-β-1,3-glucanase
Endoglucanase Segment by Application
Textile Industry
Bioenergy Production
Food Processing
Paper Industry
Other
Endoglucanase Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Endoglucanase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Endoglucanase market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Endoglucanase significant trends, drivers, influence factors in global and regions.
6. To analyze Endoglucanase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endoglucanase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Endoglucanase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endoglucanase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Endoglucanase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Endoglucanase industry.
Chapter 3: Detailed analysis of Endoglucanase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Endoglucanase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Endoglucanase in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Endo-β-1,4-glucanase
- Endo-β-1,3-glucanase
Applications
- Textile Industry
- Bioenergy Production
- Food Processing
- Paper Industry
- Other
Companies covered
- Suzhou Hongxun Biotechnology
- Shandong Longda Bio-Products
- Ningxia Xiasheng Industrial Group
- Hunan Hongying Biotechnology
- Guangdong Yiduoli Biotechnology
- Sunson Industry
- Novozymes
- Mitsubishi Chemical Foods
- Kerry Group
- EN Group
- Dyadic Netherlands
- DSM
- BIO-CAT
- Aumgene Biosciences
- Amano Enzyme
- AB Enzymes
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Endoglucanase Sales Value (2021-2032)
- 1.2.2 Global Endoglucanase Sales Volume (2021-2032)
- 1.2.3 Global Endoglucanase Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Endoglucanase Market Dynamics
- 2.1 Endoglucanase Industry Trends
- 2.2 Endoglucanase Industry Drivers
- 2.3 Endoglucanase Industry Opportunities and Challenges
- 2.4 Endoglucanase Industry Restraints
3 Endoglucanase Market by Company
- 3.1 Global Endoglucanase Company Revenue Ranking in 2025
- 3.2 Global Endoglucanase Revenue by Company (2021-2026)
- 3.3 Global Endoglucanase Sales Volume by Company (2021-2026)
- 3.4 Global Endoglucanase Average Price by Company (2021-2026)
- 3.5 Global Endoglucanase Company Ranking (2024-2026)
- 3.6 Global Endoglucanase Company Manufacturing Base and Headquarters
- 3.7 Global Endoglucanase Company Product Type and Application
- 3.8 Global Endoglucanase Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Endoglucanase Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Endoglucanase Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Endoglucanase Market by Type
- 4.1 Endoglucanase Type Introduction
- 4.1.1 Endo-β-1,4-glucanase
- 4.1.2 Endo-β-1,3-glucanase
- 4.2 Global Endoglucanase Sales Volume by Type
- 4.2.1 Global Endoglucanase Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Endoglucanase Sales Volume by Type (2021-2032)
- 4.2.3 Global Endoglucanase Sales Volume Share by Type (2021-2032)
- 4.3 Global Endoglucanase Sales Value by Type
- 4.3.1 Global Endoglucanase Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Endoglucanase Sales Value by Type (2021-2032)
- 4.3.3 Global Endoglucanase Sales Value Share by Type (2021-2032)
5 Endoglucanase Market by Application
- 5.1 Endoglucanase Application Introduction
- 5.1.1 Textile Industry
- 5.1.2 Bioenergy Production
- 5.1.3 Food Processing
- 5.1.4 Paper Industry
- 5.1.5 Other
- 5.2 Global Endoglucanase Sales Volume by Application
- 5.2.1 Global Endoglucanase Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Endoglucanase Sales Volume by Application (2021-2032)
- 5.2.3 Global Endoglucanase Sales Volume Share by Application (2021-2032)
- 5.3 Global Endoglucanase Sales Value by Application
- 5.3.1 Global Endoglucanase Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Endoglucanase Sales Value by Application (2021-2032)
- 5.3.3 Global Endoglucanase Sales Value Share by Application (2021-2032)
6 Endoglucanase Regional Sales and Value Analysis
- 6.1 Global Endoglucanase Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Endoglucanase Sales by Region (2021-2032)
- 6.2.1 Global Endoglucanase Sales by Region: 2021-2026
- 6.2.2 Global Endoglucanase Sales by Region (2027-2032)
- 6.3 Global Endoglucanase Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Endoglucanase Sales Value by Region (2021-2032)
- 6.4.1 Global Endoglucanase Sales Value by Region: 2021-2026
- 6.4.2 Global Endoglucanase Sales Value by Region (2027-2032)
- 6.5 Global Endoglucanase Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Endoglucanase Sales Value (2021-2032)
- 6.6.2 North America Endoglucanase Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Endoglucanase Sales Value (2021-2032)
- 6.7.2 Europe Endoglucanase Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Endoglucanase Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Endoglucanase Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Endoglucanase Sales Value (2021-2032)
- 6.9.2 South America Endoglucanase Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Endoglucanase Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Endoglucanase Sales Value Share by Country, 2025 VS 2032
7 Endoglucanase Country-level Sales and Value Analysis
- 7.1 Global Endoglucanase Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Endoglucanase Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Endoglucanase Sales by Country (2021-2032)
- 7.3.1 Global Endoglucanase Sales by Country (2021-2026)
- 7.3.2 Global Endoglucanase Sales by Country (2027-2032)
- 7.4 Global Endoglucanase Sales Value by Country (2021-2032)
- 7.4.1 Global Endoglucanase Sales Value by Country (2021-2026)
- 7.4.2 Global Endoglucanase Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.9.2 France Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.16.2 China Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.19.2 India Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Endoglucanase Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Endoglucanase Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Endoglucanase Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Endoglucanase Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Suzhou Hongxun Biotechnology
- 8.1.1 Suzhou Hongxun Biotechnology Company Information
- 8.1.2 Suzhou Hongxun Biotechnology Business Overview
- 8.1.3 Suzhou Hongxun Biotechnology Endoglucanase Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Suzhou Hongxun Biotechnology Endoglucanase Product Portfolio
- 8.1.5 Suzhou Hongxun Biotechnology Recent Developments
- 8.2 Shandong Longda Bio-Products
- 8.2.1 Shandong Longda Bio-Products Company Information
- 8.2.2 Shandong Longda Bio-Products Business Overview
- 8.2.3 Shandong Longda Bio-Products Endoglucanase Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Shandong Longda Bio-Products Endoglucanase Product Portfolio
- 8.2.5 Shandong Longda Bio-Products Recent Developments
- 8.3 Ningxia Xiasheng Industrial Group
- 8.3.1 Ningxia Xiasheng Industrial Group Company Information
- 8.3.2 Ningxia Xiasheng Industrial Group Business Overview
- 8.3.3 Ningxia Xiasheng Industrial Group Endoglucanase Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Ningxia Xiasheng Industrial Group Endoglucanase Product Portfolio
- 8.3.5 Ningxia Xiasheng Industrial Group Recent Developments
- 8.4 Hunan Hongying Biotechnology
- 8.4.1 Hunan Hongying Biotechnology Company Information
- 8.4.2 Hunan Hongying Biotechnology Business Overview
- 8.4.3 Hunan Hongying Biotechnology Endoglucanase Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Hunan Hongying Biotechnology Endoglucanase Product Portfolio
- 8.4.5 Hunan Hongying Biotechnology Recent Developments
- 8.5 Guangdong Yiduoli Biotechnology
- 8.5.1 Guangdong Yiduoli Biotechnology Company Information
- 8.5.2 Guangdong Yiduoli Biotechnology Business Overview
- 8.5.3 Guangdong Yiduoli Biotechnology Endoglucanase Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Guangdong Yiduoli Biotechnology Endoglucanase Product Portfolio
- 8.5.5 Guangdong Yiduoli Biotechnology Recent Developments
- 8.6 Sunson Industry
- 8.6.1 Sunson Industry Company Information
- 8.6.2 Sunson Industry Business Overview
- 8.6.3 Sunson Industry Endoglucanase Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Sunson Industry Endoglucanase Product Portfolio
- 8.6.5 Sunson Industry Recent Developments
- 8.7 Novozymes
- 8.7.1 Novozymes Company Information
- 8.7.2 Novozymes Business Overview
- 8.7.3 Novozymes Endoglucanase Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Novozymes Endoglucanase Product Portfolio
- 8.7.5 Novozymes Recent Developments
- 8.8 Mitsubishi Chemical Foods
- 8.8.1 Mitsubishi Chemical Foods Company Information
- 8.8.2 Mitsubishi Chemical Foods Business Overview
- 8.8.3 Mitsubishi Chemical Foods Endoglucanase Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Mitsubishi Chemical Foods Endoglucanase Product Portfolio
- 8.8.5 Mitsubishi Chemical Foods Recent Developments
- 8.9 Kerry Group
- 8.9.1 Kerry Group Company Information
- 8.9.2 Kerry Group Business Overview
- 8.9.3 Kerry Group Endoglucanase Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Kerry Group Endoglucanase Product Portfolio
- 8.9.5 Kerry Group Recent Developments
- 8.10 EN Group
- 8.10.1 EN Group Company Information
- 8.10.2 EN Group Business Overview
- 8.10.3 EN Group Endoglucanase Sales, Value and Gross Margin (2021-2026)
- 8.10.4 EN Group Endoglucanase Product Portfolio
- 8.10.5 EN Group Recent Developments
- 8.11 Dyadic Netherlands
- 8.11.1 Dyadic Netherlands Company Information
- 8.11.2 Dyadic Netherlands Business Overview
- 8.11.3 Dyadic Netherlands Endoglucanase Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Dyadic Netherlands Endoglucanase Product Portfolio
- 8.11.5 Dyadic Netherlands Recent Developments
- 8.12 DSM
- 8.12.1 DSM Company Information
- 8.12.2 DSM Business Overview
- 8.12.3 DSM Endoglucanase Sales, Value and Gross Margin (2021-2026)
- 8.12.4 DSM Endoglucanase Product Portfolio
- 8.12.5 DSM Recent Developments
- 8.13 BIO-CAT
- 8.13.1 BIO-CAT Company Information
- 8.13.2 BIO-CAT Business Overview
- 8.13.3 BIO-CAT Endoglucanase Sales, Value and Gross Margin (2021-2026)
- 8.13.4 BIO-CAT Endoglucanase Product Portfolio
- 8.13.5 BIO-CAT Recent Developments
- 8.14 Aumgene Biosciences
- 8.14.1 Aumgene Biosciences Company Information
- 8.14.2 Aumgene Biosciences Business Overview
- 8.14.3 Aumgene Biosciences Endoglucanase Sales, Value and Gross Margin (2021-2026)
- 8.14.4 Aumgene Biosciences Endoglucanase Product Portfolio
- 8.14.5 Aumgene Biosciences Recent Developments
- 8.15 Amano Enzyme
- 8.15.1 Amano Enzyme Company Information
- 8.15.2 Amano Enzyme Business Overview
- 8.15.3 Amano Enzyme Endoglucanase Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Amano Enzyme Endoglucanase Product Portfolio
- 8.15.5 Amano Enzyme Recent Developments
- 8.16 AB Enzymes
- 8.16.1 AB Enzymes Company Information
- 8.16.2 AB Enzymes Business Overview
- 8.16.3 AB Enzymes Endoglucanase Sales, Value and Gross Margin (2021-2026)
- 8.16.4 AB Enzymes Endoglucanase Product Portfolio
- 8.16.5 AB Enzymes Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Endoglucanase Value Chain Analysis
- 9.1.1 Endoglucanase Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Endoglucanase Sales Mode & Process
- 9.2 Endoglucanase Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Endoglucanase Distributors
- 9.2.3 Endoglucanase Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst